13.3.2018 A8-0063/10

Amendment 10 Patrizia Toia, Simona Bonafè, Damiano Zoffoli, Renata Briano, Nicola Caputo, Elena Gentile, , Mercedes Bresso, Silvia Costa, , , , Isabella De Monte, Enrico Gasbarra, Michela Giuffrida, , Cécile Kashetu Kyenge, Luigi Morgano, Alessia Maria Mosca, , Daniele Viotti, Sergio Gaetano Cofferati, Pier Antonio Panzeri, Massimo Paolucci, Elly Schlein, , Alberto Cirio, Flavio Zanonato, Renato Soru, Remo Sernagiotto, Salvatore Cicu, Stefano Maullu, Alessandra Mussolini, Lorenzo Cesa, Elisabetta Gardini, Barbara Matera, Salvatore Domenico Pogliese, , , Lara Comi

Report A8-0063/2018 Giovanni La Via Location of the seat of the European Medicines Agency COM(2017)0735 – C8-0421/2017 – 2017/0328(COD)

Proposal for a regulation Article 71 a

Text proposed by the Commission Amendment

The Agency shall have its seat in The seat of the Agency shall be located in Amsterdam, the Netherlands. a city of a Member State on the basis of absolute assurance that: - it meets, without any exception or limitation, as from January 2019, all requirements, conditions and criteria necessary to ensure that the Agency can function effectively; - it ensures the full and immediate operational continuity of the Agency’s activities, which are highly important to society and of great scientific value. The Agency's remit shall relate to what is recognised as a fundamental right of European citizens to health protection. Its headquarters shall be selected under the ordinary legislative procedure pursuant to Articles 114 and 168(4)(b) TFEU.

Or. it

AM\1148454EN.docx PE616.123v01-00

EN United in diversity EN

Justification

The amendment seeks to emphasise the need for the European Medicines Agency to have a suitable, functional seat which is operational on the date on which the UK actually leaves the EU. In addition, the wording is intended to clarify the role and prerogatives of the and the need for it to be fully involved as co-legislator.

AM\1148454EN.docx PE616.123v01-00

EN United in diversity EN